MDAI vs CERS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 20, 2026

MDAI

37.6
AI Score
VS
CERS Wins

CERS

41.2
AI Score

Investment Advisor Scores

MDAI

38score
Recommendation
SELL

CERS

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDAI CERS Winner
Revenue 7.51M 111.10M CERS
Net Income -7.59M -4.58M CERS
Net Margin -101.0% -4.1% CERS
Operating Income -6.29M -2.21M CERS
ROE 63.0% -6.5% MDAI
ROA -39.0% -2.2% CERS
Total Assets 19.44M 205.19M CERS
Cash 14.00M 17.98M CERS
Current Ratio 0.90 1.83 CERS

Relative Price Performance (Last 90 Days)

MDAI 1M: -2.4% · 3M: -39.4% CERS 1M: -2.1% · 3M: +2.6%

Current Technical Phase

MDAI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.5 · Price: $1.60

CERS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.3 · Price: $2.81

Fundamentals Snapshot

Metric MDAI CERS
Market Cap
Forward P/E -4.5 -562.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin -1.2% 0.0%
EPS -0.31 -0.03
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CERS is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.